Current Issue

Sponsored
Keywords

Stem Cell Therapeutics - Related Content

Feature Articles: Tissue Engineering Revenues Rise
Expert Tips: 10 Tips for Translational Stem Cell Therapy Research
Feature Articles: Stem Cell Applications Hasten into the Clinic
Feature Articles: Stem Cell Therapies Make Steady Progress
Preclinical Development of ESC-, iPSC-, CSC-, and CLSC-Derived Products Moves Along Briskly
Point of View: Stem Cell Research Perseveres in the Midst of Funding Crisis
Uncertainty Surrounding Federal Grants for hESC Research Advances iPSCs

New Life for Embryonic Stem Cells
February 1, 2013
Positive results from new studies show that ESCs still hold much potential for regenerative medicine.
Hearing Better Through Chemistry
December 21, 2012
Drug or stem cell therapies for hearing loss may replace mechanical devices within a few years.
Tissue Engineering No Easy Cell
October 10, 2012
A new paradigm of medicine is taking hold with regenerative medicine at the forefront, but challenges still remain.
A Clearer Regulatory Pathway for Cell Therapy May Help Improve Investment
May 2, 2011
In the U.S. and the U.K., gov’t and foundations play a key funding role as investors try to avoid the risk.
Is the Progression of Adult Stem Cell Therapies into the Clinic a Good Sign for Technology?
May 26, 2010
More firms stepping into Phase I should counter pessimism from mid- and late-stage clinical trial upsets.

STEM CELL THERAPIES ON THE RISE
- Linda Powers, Cofounder and Managing Director of Toucan Capital, is interviewed by GEN's Editor in Chief, John Sterling